Showing results (101-110 of 555) with videos related to
Sort By:
Pageof 56
Parkinsonism & Related Disorders|September 10, 2002
Degeneration of neuronal cells due to oxidative stress--microglial contributionE Koutsilieri, C Scheller, F Tribl, et al.Journal of Neural Transmission. Supplementum|January 1, 1997
Neurochemical abnormalities in Alzheimer's disease and Parkinson's disease--a comparative reviewW Gsell, I Strein, U Krause, et al.Neuropharmacology|August 1, 1985
Comparison of benzodiazepine receptor binding in membranes from human or rat brainW Sieghart, A Eichinger, P Riederer, et al.European Archives of Psychiatry and Clinical Neuroscience|February 2, 2000
Investigations on oxidative stress and therapeutical implications in dementiaN Durany, G Münch, T Michel, et al.European Neurology|January 1, 1991
Iron in brain function and dysfunction with emphasis on Parkinson's diseaseM B Youdim, D Ben-Shachar, P RiedererJournal of Neural Transmission|January 1, 1979
Effects of post-mortem storage on synaptic 5-HT binding and uptake in mammalian brainN Weiner, C Martin, W Wesemann, et al.Journal of Neural Transmission. Supplementum|April 24, 2007
Apoptosis inhibition in T cells triggers the expression of proinflammatory cytokines--implications for the CNSC Scheller, P Riederer, M Gerlach, et al.Wiener Klinische Wochenschrift|May 11, 1979
[The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)]F Podiwinsky, M Mentasti, P Riederer, et al.Journal of Neural Transmission. Supplementum|January 1, 1990
The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson's diseaseM B Youdim, D Ben-Shachar, P RiedererJournal of Neural Transmission|January 1, 1977
Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndromeP Riederer, W Birkmayer, D Seemann, et al.Pageof 56